Literature Review
of articles in

Evidence for continuous glucose monitoring: Sufficient for reimbursement?

Article · Literature ReviewinDiabetic Medicine 31(2) · October 2013with68 Reads
Lutz Heinemann at Science & Co.
  • 47.29
  • Science & Co.
Evidence for continuous glucose monitoring is mounting. Meta-analyses consistently show lowering of HbA1c , and the first trial reporting a reduction in severe hypoglycaemic events in patients with hypoglycaemia unawareness has recently been presented. The more recent trials studied larger numbers of patients and may have shown better results because of improved technology. The various combinations of pump and sensor, with automated bolus calculators and low glucose suspend features, make evaluation more challenging from a reimbursement point of view, but evidence seems convincing enough to justify reimbursement for selected patient groups, including those who have shown a substantial improvement in HbA1c during a trial period, and those with hypoglycaemia unawareness who encountered severe hypoglycaemia in the recent past. More data on cost-efficacy are needed. This article is protected by copyright. All rights reserved.

Do you want to read the rest of this article?

Full-text available
    Continuous glucose monitoring (CGM) systems have been available for more than 15 years by now. However, market uptake is relatively low in most countries; in other words, relatively few patients with diabetes use CGM systems regularly. One major reason for the reluctance of patients to use CGM systems is the costs associated (i.e., in most countries no reimbursement is provided by the health... [Show full abstract]
      In this issue of Journal of Diabetes Science and Technology, Nakamura and Balo report on accuracy and efficacy of the Dexcom G4 Platinum Continuous Glucose Monitoring System. The authors demonstrate good overall performance of this real-time continuous glucose monitoring (RT-CGM) system, although accuracy data of the next generation RT-CGM system, the G4AP, is already available. Also, now that... [Show full abstract]
        The necessity of strict glycemic control is unquestionable. However, hypoglycemia remains a major limiting factor in achieving satisfactory glucose control, and evidence is mounting to show that hypoglycemia is not benign. Over the past decade, evidence has consistently shown that real-time continuous glucose monitoring improves glycemic control in terms of lowering glycated hemoglobin levels.... [Show full abstract]
          To the Editor: Bergenstal et al. (July 18 issue)(1) report a reduction in nocturnal hypoglycemia with the use of the low-glucose (or threshold) suspend feature of an insulin pump combined with a continuous glucose monitor. Not only was the time patients spent in hypoglycemia reduced, but also the rate of nocturnal events was 31.8% lower in the intervention group. This finding is remarkable... [Show full abstract]
          Discover more